Risk factors for liver enzyme elevation with remdesivir use in the treatment of paediatric COVID-19.
Tsuyoshi JindaShinsuke MizunoShunsuke TatamiMasashi KasaiTatsuhiko IshidaPublished in: Journal of paediatrics and child health (2024)
Liver enzyme elevation was reversible after discontinuing RDV use. Overall, RDV can be considered safe in children with careful monitoring.